Ductal carcinoma-in-situ

Journal of Clinical Oncology

Volumn 19, Issue 18 SUPPL., 2001, Pages

  Wickerham, D L ^a  

^a National Surgical Adjuvant Breast   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; CONFERENCE PAPER; FEMALE; HUMAN; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DECISION MAKING; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TAMOXIFEN;

EID: 0035884229     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Ductal carcinoma in situ (DCIS) of the breast: Evolving perspectives
2. Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast
3. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
4. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
5. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17
6. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: Intraductal carcinoma
7. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Intraductal carcinoma (ductal carcinoma in situ) - The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators
8. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853 - EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
9. Tamoxifen for early breast cancer: An overview of the randomised trials - Early Breast Cancer Trialists' Collaborative Group
10. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
11. Treatment of primary breast cancer with chemotherapy and tamoxifen
12. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: Results from the National Surgical Adjuvant Breast and Bowel Project B-16
13. A randomized clinical trial evaluating tamoxifen in the treatment of patients with nodenegative breast cancer who have estrogen-receptor-positive tumors
14. Systemic therapy in patients with node-negative breast cancer: A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials
15. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
16. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
17. Effect of tamoxifen (ICI 46, 474) on initiation and growth of DMBA-induced rat mammary carcinomata
18. Evaluation of the antitumor activity of the nonsteroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model
19. The role of radiotherapy and tamoxifen in the management of node negative invasive breast cancer -1.0 cm treated with lumpectomy: Preliminary results of NSABP Protocol B-21